Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

NCT02960880 · clinicaltrials.gov ↗

COMPLETED

Status

99999

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Rivaroxaban (Xarelto, BAY597939)
DRUG: Phenprocoumon (branded and generics)

Sponsor

Bayer

Collaborators

[object Object]